Challenges in developing and studying treatments call for new ways of thinking about cancer research.

by Eric Fitzsimmons

FDA approves an antibody-drug conjugate for people with HER2-ultralow breast cancer, and historic redlining practices have a lingering impact on cancer outcomes.

by Thomas Celona

A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.

by Sandra Gordon

Studies underscore the strength of exercise recommendations, and new radiation therapy technique poised to make a flash.

by Marci A. Landsmann

Cancer incidence on the rise in younger women, and a new report issued on alcohol and health.

by Kevin McLaughlin

New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.

by Laura Gesualdi-Gilmore

Getting more calcium could lower risk for colorectal cancer, and research provides new insight into which BRCA2 mutations can lead to cancer.

by Thomas Celona

Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.

by Kyle Bagenstose

New year brings debate about dangers of alcohol, and insurance denials continue to delay care.

by Marci A. Landsmann